ToxSci Advance Access published online on September 27, 2006
Toxicological Sciences, doi:10.1093/toxsci/kfl117
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Center for Environmental & Human Toxicology, University of Florida, Gainesville, FL 32611, U.S.A.
* To whom correspondence should be addressed. A number of studies have found that GI absorption of arsenic from soil is limited, indicating that a relative oral bioavailability (RBA) adjustment is warranted when calculating risks from exposure to arsenic contaminated soil. However, few studies of arsenic bioavailability from soil have been conducted in animal models with phylogenetic similarity to humans, such as non-human primates. We report here the results of a study in which the RBA of arsenic in soil from a variety of types of contaminated sites was measured in male cynomolgus monkeys. A single oral dose of each contaminated soil was administered to five adult male cynomolgus monkeys by gavage, and the extent of oral absorption was evaluated through measurement of arsenic recovery in urine and feces. Urinary recovery of arsenic following doses of contaminated soil were compared with urinary recovery following oral administration of sodium arsenate in water in order to determine the RBA of each soil. RBA of arsenic in 14 soil samples from 12 different sites ranged from 0.05 to 0.31 (5 to 31%), with most RBA values in the 0.1 to 0.2 (10 to 20%) range. The RBA values were found to be inversely related to the amount of arsenic present with iron sulfate. No other significant correlations were observed between RBA and arsenic mineralogic phases in the test soils. The lack of clear relationships between arsenic mineralogy and RBA measured in vivo suggests that gastrointestinal absorption of arsenic from soil may be more complex than originally thought, and subject to factors other than simple dissolution behavior.
Received July 6, 2006
Accepted September 18, 2006
Risk Assessment
Relative Oral Bioavailability of Arsenic from Contaminated Soils Measured in the Cynomolgus Monkey
Stephen M. Roberts 1 *, John W. Munson 1, Yvette W Lowney 2, and Michael V. Ruby 2
2 Exponent, Boulder, CO 80301, U.S.A.
Stephen M. Roberts, E-mail: smr{at}ufl.edu
![]()
Abstract ![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S. R. Walker, M. B. Parsons, H. E. Jamieson, and A. Lanzirotti ARSENIC MINERALOGY OF NEAR-SURFACE TAILINGS AND SOILS: INFLUENCES ON ARSENIC MOBILITY AND BIOACCESSIBILITY IN THE NOVA SCOTIA GOLD MINING DISTRICTS Can Mineral, June 1, 2009; 47(3): 533 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. B. Crouse, M. W. Michie, M. A. Major, G. J. Leach, and G. Reddy Oral Bioavailability of Cyclotrimethylenetrinitramine (RDX) from Contaminated Site Soils in Rats International Journal of Toxicology, July 1, 2008; 27(4): 317 - 322. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. W. Lowney, R. C. Wester, R. A. Schoof, C. A. Cushing, M. Edwards, and M. V. Ruby Dermal Absorption of Arsenic from Soils as Measured in the Rhesus Monkey Toxicol. Sci., December 1, 2007; 100(2): 381 - 392. [Abstract] [Full Text] [PDF] |
||||


